- Report
- March 2025
- 185 Pages
Global
From €4017EUR$4,500USD£3,493GBP
- Report
- March 2025
- 180 Pages
Global
From €4017EUR$4,500USD£3,493GBP
- Report
- March 2025
- 180 Pages
Global
From €4017EUR$4,500USD£3,493GBP
- Report
- January 2025
- 180 Pages
Global
From €4017EUR$4,500USD£3,493GBP
- Report
- March 2025
- 150 Pages
Global
From €3437EUR$3,850USD£2,988GBP
€4330EUR$4,850USD£3,765GBP
- Report
- March 2025
- 150 Pages
Global
From €3437EUR$3,850USD£2,988GBP
€4330EUR$4,850USD£3,765GBP
- Report
- March 2025
- 150 Pages
Global
From €3437EUR$3,850USD£2,988GBP
€4330EUR$4,850USD£3,765GBP
- Report
- March 2025
- 150 Pages
Global
From €3437EUR$3,850USD£2,988GBP
€4330EUR$4,850USD£3,765GBP
- Report
- March 2025
- 150 Pages
Global
From €3437EUR$3,850USD£2,988GBP
€4330EUR$4,850USD£3,765GBP
- Report
- February 2025
- 150 Pages
Global
From €3437EUR$3,850USD£2,988GBP
€4330EUR$4,850USD£3,765GBP
- Report
- February 2025
- 150 Pages
Global
From €3437EUR$3,850USD£2,988GBP
€4330EUR$4,850USD£3,765GBP
- Report
- July 2025
- 226 Pages
Global
From €3973EUR$4,450USD£3,454GBP
- Report
- July 2025
- 350 Pages
Global
From €4418EUR$4,949USD£3,841GBP
- Report
- July 2025
- 112 Pages
Global
From €3500EUR$4,200USD£3,150GBP
- Report
- September 2025
- 135 Pages
Global
From €3680EUR$4,123USD£3,200GBP
€4330EUR$4,850USD£3,765GBP
- Report
- July 2025
- 210 Pages
Global
From €3680EUR$4,123USD£3,200GBP
€4330EUR$4,850USD£3,765GBP
- Report
- April 2025
- 160 Pages
Global
From €3680EUR$4,123USD£3,200GBP
€4330EUR$4,850USD£3,765GBP
- Report
- March 2025
- 130 Pages
Global
From €3680EUR$4,123USD£3,200GBP
€4330EUR$4,850USD£3,765GBP
- Report
- July 2025
- 250 Pages
Asia Pacific
From €3454EUR$3,869USD£3,003GBP
- Report
- June 2025
- 300 Pages
Latin America
From €3454EUR$3,869USD£3,003GBP

The Conjugate Vaccine market is a subset of the Vaccines market, which is composed of products designed to prevent and treat infectious diseases. Conjugate Vaccines are a type of vaccine that combines a polysaccharide antigen with a protein carrier, which helps the body to recognize the antigen and mount an immune response. These vaccines are used to protect against a variety of bacterial infections, including meningitis, pneumonia, and sepsis.
Conjugate Vaccines are typically administered to infants and young children, as their immune systems are not yet fully developed and are more susceptible to certain infections. In addition, these vaccines are often used in combination with other vaccines to provide broader protection against multiple diseases.
Notable companies in the Conjugate Vaccine market include GlaxoSmithKline, Merck & Co., Pfizer, Sanofi, and Novartis. Show Less Read more